Similar biologics in India: A story of access or potential for compromise?

by Ramesh Jois, Sukumar Mukherjee, S Rajeswari, P D Rath, Vishal Goyal, Disha Gupta
Published 2020-01-01

Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India

by Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee
Published 2021-01-01